First-Line Aumolertinib in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Retrospective Study with a Four-Year Follow-Up. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.